News
Stay up to date with the latest from AI Biomedical Inc.
AI Biomedical Selected for METI's "Japan Innovation Campus" in Silicon Valley
Selected as a 4th cohort coworking member of the Ministry of Economy, Trade and Industry's Silicon Valley hub "Japan Innovation Campus." Full-scale U.S. business operations to begin in 2026.
AIBM Quantum Dream Studio Tokyo Opens at Kotsu Kaikan
A new R&D hub opened at 6F Tokyo Kotsu Kaikan, 2-10-1 Yurakucho, Chiyoda-ku, Tokyo, promoting R&D using quantum AI and advanced Physical AI technology.
Toward the World's First "Physical AI" Medical Platform — Project Hawaii Launches
AIBM, Edison AI, and BeMap launch a 3-year plan to synchronize the real and virtual worlds through digital twin, bio-3D printer, and communication technologies.
AI Biomedical's "AI Regenerative Medicine Revolution" Launches in Full
New management structure announced. World-first QUANTUM method (AI × 5-axis 3D bioprinting × digital twin) aims to develop pediatric regenerative artificial hearts.
Artissue Inc., a Regenerative Medicine Design Company, Founded
Artissue Inc., predecessor of AI Biomedical Inc., founded in Chiyoda-ku, Tokyo, with a mission to "create happiness for the next generation through regenerative organ revolution."